Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation
Full text] Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
Types of Multiple Myeloma | International Myeloma Foundation
UHL GP NEWS
Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez
IgG4-related disease: what a hematologist needs to know | Haematologica
Getting to Know Mr.CRAB
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
Full text] Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
UHL GP NEWS
Monoclonal Gammopathy Case Studies - Insights
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
Pseudo-monoclonal gammopathy: a report of four cases | Haematologica
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma - Abbi - 2016 - British Journal of Haematology - Wiley Online Library
Clinical utility of serum IgG4 measurement - ScienceDirect
PDF) Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies
Antibody - Wikipedia
Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez
PDF) Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials
Pseudo-monoclonal gammopathy: a report of four cases